Patent · US Active

Ink formulation and manufacture thereof

US8709142B2 · kind B2 · utility

7Cited by
10References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 23, 2012
Grant dateApr 29, 2014
Priority date
Expiry dateOct 25, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC09D11/037
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An ink formulation for marking living tissue comprises a dispersion of carbon black pigment particles encapsulated in water soluble shells, mixed with a pharmaceutically accepted carrier, such as water, and a preservative. A dispersion formulation is preferential to a suspension formulation for marking living tissue because the carbon particles of the dispersion formulation are less likely to aggregate and sediment over time. In addition, the absence of large quantities of additives makes a dispersion formulation less reactive to living tissue, further enhancing its appeal as a biological marker.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.